From the Division of Vascular Medicine and Pharmacology (K.I., A.M.B.), Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Division of Preventive Medicine (P.M.R., J.E.B.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Epidemiology (P.M.R., J.E.B., T.K.), Harvard T.H. Chan School of Public Health, Boston, MA; PLoegh Lab (C.C.), Program in Cellular and Molecular Medicine (PCMM), Boston Children Hospital and Harvard Medical School, MA; Center for Stroke Research (J.L.R.), Charité-Universitätsmedizin Berlin, Germany; and Institute of Public Health (J.L.R., T.K.), Charité-Universitätsmedizin Berlin, Germany.
Neurology. 2022 Oct 17;99(16):e1694-e1701. doi: 10.1212/WNL.0000000000201009.
Migraine has consistently been associated with an increased risk of cardiovascular disease (CVD) events. It remains, however, unclear to what extent cardiovascular risk profiles might be linked with migraine activity status and how these profiles relate to the development of migraine.
We used data from a cohort study of female health professionals (Women's Health Study, n = 27,539, age ≥45 years at baseline) without a history of CVD or other major diseases and who provided a blood sample at baseline. Framingham risk scores (FRSs) estimating the 10-year risk of coronary heart disease calculated at baseline were used to create vascular risk categories. The presence or development of self-reported migraine was assessed by questionnaires. Women were classified as having no migraine, history of migraine (experienced migraine in the past but did not experience any migraine attacks in the year before enrollment), active migraine at baseline (active), or incident migraine (first report of migraine during follow-up but not at baseline). We used multinomial logistic regression models to calculate ORs for the association between FRS categories and migraine status.
Of the 27,539 participants, a total of 21,927 women did not report migraine, 1,500 women reported a history of migraine, 3,579 had migraine at baseline, and 533 reported migraine for the first time during follow-up. The odds of the probability of having a history of migraine at baseline (vs never migraine) was 76% higher among those with FRS ≥10% compared with FRS ≤1% after adjustment (OR = 1.76, 95% CI 1.39-2.23). In contrast, having FRS ≥10% was associated with reduced odds of having active migraine at baseline (OR = 0.64, 95% CI 0.52-0.80) and with newly reported migraine during follow-up (OR = 0.42, 95% CI 0.22-0.81) when compared with women with FRS category ≤1% and those not reporting migraine. A similar association pattern was observed for FRS categories 5%-9% and 2%-4%.
High FRS categories were only observed among women with a history of migraine but not with active migraine at baseline or incident migraine after baseline. Our results suggest that the life course of migraine should be considered when studying associations with the vascular system. Our data further suggest that a relatively healthy vascular system, as assessed by the FRS, is associated with active migraine status or developing migraine in the future.
偏头痛与心血管疾病(CVD)事件的风险增加一直相关。然而,尚不清楚心血管风险状况在多大程度上可能与偏头痛活动状态有关,以及这些状况与偏头痛的发展有何关系。
我们使用了一项女性健康专业人员队列研究(女性健康研究,n=27539,基线时年龄≥45 岁)的数据,这些专业人员无 CVD 或其他重大疾病史,并在基线时提供了一份血样。使用Framingham 风险评分(FRS)来估计基线时的冠心病 10 年风险,以此来创建血管风险类别。通过问卷调查评估是否存在或发生偏头痛。女性被分为无偏头痛、偏头痛史(过去曾经历过偏头痛,但在入组前一年没有发生任何偏头痛发作)、基线时偏头痛活跃(活跃)或偶发性偏头痛(随访期间首次报告偏头痛,但基线时没有)。我们使用多变量逻辑回归模型来计算 FRS 类别与偏头痛状态之间的比值比(OR)。
在 27539 名参与者中,共有 21927 名女性未报告偏头痛,1500 名女性报告有偏头痛史,3579 名女性基线时偏头痛活跃,533 名女性在随访期间首次报告偏头痛。与 FRS≤1%的女性相比,FRS≥10%的女性基线时发生偏头痛史(vs 从未发生偏头痛)的概率高出 76%(OR=1.76,95%CI 1.39-2.23)。相比之下,与 FRS 类别≤1%的女性和不报告偏头痛的女性相比,FRS≥10%的女性基线时偏头痛活跃(OR=0.64,95%CI 0.52-0.80)和随访期间新发偏头痛(OR=0.42,95%CI 0.22-0.81)的几率较低。FRS 类别 5%-9%和 2%-4%也观察到了类似的关联模式。
高 FRS 类别仅见于有偏头痛史的女性,而不是基线时偏头痛活跃或基线后偶发性偏头痛的女性。我们的结果表明,在研究与血管系统的关联时,应考虑偏头痛的生命历程。我们的数据进一步表明,根据 FRS 评估的相对健康的血管系统与基线时的偏头痛活跃状态或未来发生偏头痛有关。